Alexithymia as a risk factor for type 2 diabetes mellitus in the metabolic syndrome: A cross-sectional study

Psychiatry Research

Volumn 215, Issue 2, 2014, Pages 438-443

  Lemche, Alexandra V ^a   Chaban, Oleg S ^b   Lemche, Erwin ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Cross sectional studies; Metabolic syndrome; National cohort; Relative risk; Toronto Alexithymia Scale; Type 2 diabetes mellitus

Indexed keywords

ADULT; BLOOD PRESSURE; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; EMOTIONAL DISORDER; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR;

ADULT; AFFECTIVE SYMPTOMS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84893814146     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.12.004     Document Type: Article

References (32)

1. Bagby R.M., Parker J.D., Taylor G.J. The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure. Journal of Psychosomatic Research 1994, 38:23-32.
2. Bagby R.M., Taylor G.J., Parker J.D. The Twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. Journal of Psychosomatic Research 1994, 38:33-40.
3. Batterham R.L., Ffytche D.H., Rosenthal J.M., Zelaya F.O., Barker G.J., Withers D.J., Williams S.C. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450:106-109.
4. Chatzi L., Bitsios P., Solidaki E., Christou I., Kyrlaki E., Sfakianaki M., Kogevinas M., Kefalogiannis N., Pappas A. Type 1 diabetes is associated with alexithymia in nondepressed, non-mentally ill diabetic patients: a case-control study. Journal of Psychosomatic Research 2009, 67(4):307-313.
5. de Timary P., Roy E., Luminet O., Fillee C., Mikolajczak M. Relationship between alexithymia, alexithymia factors and salivary cortisol in men exposed to a social stress test. Psychoneuroendocrinology 2008, 33:1160-1164.
6. Eckel R.H., Alberti K.G., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2010, 375:181-183.
7. Elfhag K., Lundh L.G. TAS-20 alexithymia in obesity, and its links to personality. Scandinavian Journal of Psychology 2007, 48:391-398.
8. Eriksson A.K., Gustavsson J.P., Hilding A., Granath F., Ekbom A., Ostenson C.G. Personality traits and abnormal glucose regulation in middle-aged Swedish men and women. Diabetes Research and Clinical Practice 2012, 95:145-152.
9. Fisher L., Glasgow R.E., Strycker L.A. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care 2010, 33:1034-1036.
10. Fisher L., Mullan J.T., Arean P., Glasgow R.E., Hessler D., Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010, 33:23-28.
11. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Journal of the American Medical Association 2002, 287:356-359.
12. Gathercole L.L., Stewart P.M. Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. J. Steroid. Biochem. Mol. Biol. 2010, 122(1-3):21-27.
13. Ginsberg H.N., Stalenhoef A.F. The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. Journal of Cardiovascular Risk 2003, 10:121-128.
14. Girman C.J., Rhodes T., Mercuri M., Pyorala K., Kjekshus J., Pedersen T.R., Beere P.A., Gotto A.M., Clearfield M. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). American Journal of Cardiology 2004, 93:136-141.
15. Gois C., Barbosa A., Ferro A., Santos A.L., Sousa F., Akiskal H., Akiskal K., Figueira M.L. The role of affective temperaments in metabolic control in patients with type 2 diabetes. Journal of Affective Disorders 2011, 134:52-58.
16. Grabe H.J., Schwahn C., Barnow S., Spitzer C., John U., Freyberger H.J., Schminke U., Felix S., Volzke H. Alexithymia, hypertension, and subclinical atherosclerosis in the general population. Journal of Psychosomatic Research 2010, 68:139-147.
17. Helmers K.F., Mente A. Alexithymia and health behaviors in healthy male volunteers. Journal of Psychosomatic Research 1999, 47:635-645.
18. Housiaux M., Luminet O., Van Broeck N., Dorchy H. Alexithymia is associated with glycaemic control of children with type 1 diabetes. Diabetes & Metabolism 2010, 36:455-462.
19. Huang C.F., Cheng M.L., Fan C.M., Hong C.Y., Shiao M.S. Nicotinuric acid: a potential marker of metabolic syndrome through a metabolomics-based approach. Diabetes Care 2013, 36:1729-1731.
20. Kauhanen J., Kaplan G.A., Cohen R.D., Salonen R., Salonen J.T. Alexithymia may influence the diagnosis of coronary heart disease. Psychosomatic Medicine 1994, 56:237-244.
21. Lemche E., Klann-Delius G., Koch R., Joraschky P. Mentalizing language development in a longitudinal attachment sample: implications for alexithymia. Psychotherapy and Psychosomatics 2004, 73:366-374.
22. Lemche E., Surguladze S.A., Giampietro V.P., Brammer M.J., Williams S.C.R., Sierra M., David A.S., Phillips M.L. Interoceptive-reflective regions differentiate alexithymia traits in depersonalization disorder. Psychiatry Research Neuroimaging 2013, 214(1):66-72.
23. Luminet O., de Timary P., Buysschaert M., Luts A. The role of alexithymia factors in glucose control of persons with type 1 diabetes: a pilot study. Diabetes & Metabolism 2006, 32:417-424.
24. Maggini C., Raballo A. Alexithymia and schizophrenic psychopathology. Acta Bio Medica 2004, 75:40-49.
25. Meunier J., Dorchy H., Luminet O. Does family cohesiveness and parental alexithymia predict glycaemic control in children and adolescents with diabetes?. Diabetes & Metabolism 2008, 34:473-481.
26. Neumann S.A., Sollers J.J., Thayer J.F., Waldstein S.R. Alexithymia predicts attenuated autonomic reactivity, but prolonged recovery to anger recall in young women. International Journal of Psychophysiology 2004, 53:183-195.
27. Puustinen P.J., Koponen H., Kautiainen H., Mantyselka P., Vanhala M. Psychological distress predicts the development of the metabolic syndrome: a prospective population-based study. Psychosomatic Medicine 2011, 73:158-165.
28. Riediger N.D., Clara I. Prevalence of metabolic syndrome in the Canadian adult population. Canadian Medical Association Journal 2011, 183:E1127-1134.
29. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., Isles C., Macfarlane P.W., Packard C.J., Cobbe S.M., Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108:414-419.
30. Szmukler G., Everitt B., Leese M. Risk assessment and receiver operating characteristic curves. Psychological Medicine 2012, 42:895-898.
31. Topsever P., Filiz T.M., Salman S., Sengul A., Sarac E., Topalli R., Gorpelioglu S., Yilmaz T. Alexithymia in diabetes mellitus. Scottish Medical Journal 2006, 51:15-20.
32. Wood R.L., Williams C., Kalyani T. The impact of alexithymia on somatization after traumatic brain injury. Brain Injury 2009, 23:649-654.